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TEER Assay Analysis
Conclusions and Future Work
• Data analyzed from the TEER assay (Fig. 3) suggest that treatment with the inflammatory 
mediator LPS affected barrier integrity in comparison to the untreated cultures.
• BMEC cultures grown on a collagen-fibronectin ECM in the transwell inserts exhibited 
ZO-1 tight junction proteins in a “cobblestone” pattern (Fig. 4C), which is typical of 
endothelial monolayers.
• Optimization of the in vitro blood brain barrier model is ongoing with the future goal of 
utilizing additional cell types in the model that are also implicated in the blood brain 
barrier, as well as using other iPSC lines.
• Future projects may incorporate RT-PCR and confocal imaging to further investigate acute 
neuro-inflammation in the blood brain barrier model.
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Introduction
The blood brain barrier is composed of specialized endothelial cells that function as 
a barrier for the central nervous system (CNS).1 The barrier must be considered in 
drug development for CNS disorders, and impaired function is associated with 
neurological conditions such as Alzheimer’s disease and stroke.1
The purpose of this experiment was to develop an in vitro model of the blood brain 
barrier that incorporated brain endothelial microvascular cells (BMEC) and co-
cultures composed of neurons, astrocytes, and macrophages. All cell types were 
derived from human induced pluripotent stem cells (iPSC) with the BMEC 
differentiation protocol adapted from Stebbins et al. (2015). The neurons, astrocytes, 
and macrophages were differentiated separately in accordance to the protocols 
utilized3,4,5, and then seeded together when the cultures reached maturity. A 12-well 
transwell plate format was used for the barrier model; the BMEC cultures were 
seeded in the transwell inserts and the co-cultures were seeded in the bottom wells. 
The inserts were coated with collagen and fibronectin, and a Matrigel ECM was 
used for the bottom wells. A transendothelial electrical resistance (TEER) assay was 
used as an investigation of barrier function. Barrier function was also evaluated with 
immunofluorescence by staining for ZO-1 tight junction markers, which are 
associated with endothelial monolayers. In addition, the model was used to 
investigate acute neuro-inflammatory responses. Inflammation was induced with the 
pro-inflammatory mediators poly I:C and LPS, and then barrier integrity was 
evaluated using the TEER assay. An in vitro model of the blood brain barrier could 
be a valuable tool to observe and assess neuro-inflammatory responses because a 
human stem cell model is more physiologically relevant.
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Figure 1. Protocol for differentiating BMEC cultures; adapted 
from Stebbins et al. (2015)
Cell Morphology 
Figure 4.
A. Untreated BMEC Day 12 100x; 
arrows indicate cobblestone pattern 
associated with monolayers
B. iPSC-derived neurons 200x
C. Untreated BMEC Day 14 
widefield 20x; stained with ZO-1 
tight junction marker
Figure 3. TEER assay analysis for treated and untreated cultures; TEER 
measurements were taken at 24-hour timepoints starting at Day 10, 
cultures were treated with LPS on Day 12 (indicated by arrow)
A. BMEC cultures in transwell inserts; no cultures in bottom wells
B. BMEC cultures in transwell inserts; neuron cultures in bottom wells




Figure 2. Diagram of co-cultures in 
transwell plate format and TEER 





















TEER Assay for Treated BMEC vs. Untreated BMEC

























TEER Assay for Treated BMEC + Neurons vs. Untreated BMEC + Neurons  

























TEER Assay for Treated BMEC + Neurons/Astrocytes vs. Untreated BMEC 
+ Neurons/Astrocytes
neuron/astrocyte 1+LPS neuron/astrocyte 2A
B
C
